CASC 2: An emerging tumour‐suppressing long noncoding RNA in human cancers and melanoma
- 9 August 2018
- journal article
- review article
- Published by Wiley in Cell Proliferation
- Vol. 51 (6) , e12506
Abstract
Deregulation of long noncoding RNA s (lnc RNA s) has been implicated in tumourigenesis. Cancer Susceptibility Candidate 2 ( CASC 2) is a lnc RNA downregulated in multiple cancer types, including endometrial, lung, gastric and colorectal cancers. CASC 2 functions as a tumour‐suppressive lnc RNA though multiple mechanisms, such as sequestration of oncogenic micro RNA s and repression of Wnt/β‐catenin signalling. Pertinent to clinical practice, the use of CASC 2 as a prognostic marker has been demonstrated in sporadic studies. These findings suggested that CASC 2 might play an important role in human cancers and melanoma. More efforts are warranted to examine the function role of CASC 2 in other cancer types. Further validation is also needed to promote its development to be a clinically utilizable prognostic biomarker.Keywords
This publication has 42 references indexed in Scilit:
- Molecular markers in gliomaJournal of Neuro-Oncology, 2017
- LncRNA CASC2 Interacts With miR‐181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN PathwayJournal of Cellular Biochemistry, 2017
- NEAT1: A novel cancer‐related long non‐coding RNACell Proliferation, 2017
- LincRNA-p21 Impacts Prognosis in Resected Non–Small Cell Lung Cancer Patients through Angiogenesis RegulationJournal of Thoracic Oncology, 2016
- TUG 1: a pivotal oncogenic long non‐coding RNA of human cancersCell Proliferation, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Adult Renal Cell CarcinomaSurgical Pathology Clinics, 2015
- The emerging role of lncRNAs in cancerNature Medicine, 2015
- Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality databaseBMJ, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015